Cvs Pharmacy #04079 | |
5603 Baltimore National Pike, Baltimore, Maryland 21228 | |
(410) 744-1422 |
Name | Cvs Pharmacy #04079 |
---|---|
Organization Name | Maryland Cvs Pharmacy Llc. |
Location | 5603 Baltimore National Pike, Baltimore, Maryland 21228 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (410) 744-1422 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers have found that the drug Lipitor which is normally used to lower cholesterol, can cut the risk of a second stroke when used in double doses.
Emergent BioSolutions Inc. announced today it has entered into a definitive agreement to acquire Trubion Pharmaceuticals, Inc. for upfront consideration of $96.8 million of value and up to $38.7 million of success-based milestones, resulting in a total consideration of up to $135.5 million. The acquisition will diversify Emergent's product development pipeline with the addition of Trubion's two clinical-stage product candidates focused on the targeted disease areas of oncology and autoimmunity.
The effects of fruit and vegetable consumption on colorectal cancer (CRC) appear to differ by site of origin, according to a new study published in the October issue of the Journal of the American Dietetic Association.
Emergen-C Immune+(TM) is a new formula providing a fun, healthy and convenient way to get a concentrated boost of immune-strengthening nutrients. The new Emergen-C Immune+ is comprised of the original Emergen-C(®)( )formula, containing 1,000 milligrams of vitamin C, plus a proprietary immune complex with beta glucans, a healthy dose of zinc and a host of other nutrients - all working together to help support the body's natural immune function.
Allos Therapeutics, Inc. today reported updated results from the Company's Phase 1 dose-finding study of FOLOTYN® (pralatrexate injection) which supports the selection of 15 mg/m2 weekly for three weeks out of a four-week cycle as the optimal starting dose and schedule for further evaluation in patients with relapsed or refractory cutaneous T-cell lymphoma. Data were presented at the 52nd American Society of Hematology Annual Meeting in Orlando, Florida.
› Verified 9 days ago
NPI Number | 1043313562 |
Organization Name | MARYLAND CVS PHARMACY LLC |
Doing Business As | CVS PHARMACY 04079 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 5603 Baltimore National Pike, Baltimore, MD 21228 |
Phone Number | 410-744-1422 |
News Archive
Researchers have found that the drug Lipitor which is normally used to lower cholesterol, can cut the risk of a second stroke when used in double doses.
Emergent BioSolutions Inc. announced today it has entered into a definitive agreement to acquire Trubion Pharmaceuticals, Inc. for upfront consideration of $96.8 million of value and up to $38.7 million of success-based milestones, resulting in a total consideration of up to $135.5 million. The acquisition will diversify Emergent's product development pipeline with the addition of Trubion's two clinical-stage product candidates focused on the targeted disease areas of oncology and autoimmunity.
The effects of fruit and vegetable consumption on colorectal cancer (CRC) appear to differ by site of origin, according to a new study published in the October issue of the Journal of the American Dietetic Association.
Emergen-C Immune+(TM) is a new formula providing a fun, healthy and convenient way to get a concentrated boost of immune-strengthening nutrients. The new Emergen-C Immune+ is comprised of the original Emergen-C(®)( )formula, containing 1,000 milligrams of vitamin C, plus a proprietary immune complex with beta glucans, a healthy dose of zinc and a host of other nutrients - all working together to help support the body's natural immune function.
Allos Therapeutics, Inc. today reported updated results from the Company's Phase 1 dose-finding study of FOLOTYN® (pralatrexate injection) which supports the selection of 15 mg/m2 weekly for three weeks out of a four-week cycle as the optimal starting dose and schedule for further evaluation in patients with relapsed or refractory cutaneous T-cell lymphoma. Data were presented at the 52nd American Society of Hematology Annual Meeting in Orlando, Florida.
› Verified 9 days ago
News Archive
Researchers have found that the drug Lipitor which is normally used to lower cholesterol, can cut the risk of a second stroke when used in double doses.
Emergent BioSolutions Inc. announced today it has entered into a definitive agreement to acquire Trubion Pharmaceuticals, Inc. for upfront consideration of $96.8 million of value and up to $38.7 million of success-based milestones, resulting in a total consideration of up to $135.5 million. The acquisition will diversify Emergent's product development pipeline with the addition of Trubion's two clinical-stage product candidates focused on the targeted disease areas of oncology and autoimmunity.
The effects of fruit and vegetable consumption on colorectal cancer (CRC) appear to differ by site of origin, according to a new study published in the October issue of the Journal of the American Dietetic Association.
Emergen-C Immune+(TM) is a new formula providing a fun, healthy and convenient way to get a concentrated boost of immune-strengthening nutrients. The new Emergen-C Immune+ is comprised of the original Emergen-C(®)( )formula, containing 1,000 milligrams of vitamin C, plus a proprietary immune complex with beta glucans, a healthy dose of zinc and a host of other nutrients - all working together to help support the body's natural immune function.
Allos Therapeutics, Inc. today reported updated results from the Company's Phase 1 dose-finding study of FOLOTYN® (pralatrexate injection) which supports the selection of 15 mg/m2 weekly for three weeks out of a four-week cycle as the optimal starting dose and schedule for further evaluation in patients with relapsed or refractory cutaneous T-cell lymphoma. Data were presented at the 52nd American Society of Hematology Annual Meeting in Orlando, Florida.
› Verified 9 days ago
Santa Monica Pharmacy And Medical S Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4300 Belair Rd, Baltimore, Maryland 21206 Phone: (410) 617-0116 | |
Rite Aid Pharmacy 00349 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4380 Park Heights Ave, Baltimore, Maryland 21215 Phone: (410) 664-8644 | |
Rite Aid Pharmacy 02214 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2855 Smith Ave, Baltimore, Maryland 21209 Phone: (410) 484-3200 | |
Rite Aid Pharmacy 00356 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3804 Liberty Heights Ave, Baltimore, Maryland 21215 Phone: (410) 367-5151 | |
Rite Aid Pharmacy 00385 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5804 Ritchie Hwy, Baltimore, Maryland 21225 Phone: (410) 789-3775 |